Adrenal androgens are weak androgenic steroid hormones produced primarily by the zona reticularis of the adrenal cortex. The principal adrenal androgens include dehydroepiandrosterone, dehydroepiandrosterone sulfate, and androstenedione, which can serve as precursors for more potent androgens and estrogens in peripheral tissues.
Adrenal androgens are steroid hormones produced by the adrenal cortex, predominantly within the zona reticularis. The major adrenal androgenic steroids are dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEAS), and androstenedione. These hormones have relatively weak intrinsic androgenic activity compared with testosterone and dihydrotestosterone, but they are important because they can be converted into more potent androgens or estrogens in peripheral tissues.
The adrenal glands produce androgenic steroids in both males and females. Their physiological importance differs according to sex, age, gonadal function, and the ability of peripheral tissues to convert adrenal precursors into biologically active sex steroids. Adrenal androgen production becomes particularly prominent during adrenarche in childhood and contributes to the development of pubic and axillary hair.
Adrenal androgen synthesis is closely related to cortisol synthesis because both pathways begin with cholesterol and share several steroidogenic intermediates. Production is influenced primarily by adrenocorticotropic hormone (ACTH), although the regulation of adrenal androgen secretion is not identical to that of cortisol.
Adrenal androgens are produced within the adrenal cortex, particularly the zona reticularis.
The adrenal cortex is organized into three major zones:
| Zone | Major Hormonal Products |
|---|---|
| Zona glomerulosa | Mineralocorticoids, especially aldosterone |
| Zona fasciculata | Glucocorticoids, especially cortisol |
| Zona reticularis | Adrenal androgens, particularly DHEA and DHEAS |
The zona reticularis is the innermost layer of the adrenal cortex and lies immediately external to the adrenal medulla.
Its steroidogenic cells are arranged in an interconnected network and contain the enzymes required for substantial production of androgen precursors.
The principal androgenic steroids produced directly or indirectly by the adrenal cortex include:
Small quantities of other androgenic steroids may also be produced.
Dehydroepiandrosterone (DHEA) is an important steroid produced by the zona reticularis.
DHEA itself has relatively weak androgenic activity but serves as an important precursor from which peripheral tissues can synthesize more potent androgens and estrogens.
Dehydroepiandrosterone sulfate (DHEAS) is the sulfated form of DHEA and is produced in large quantities by the adrenal cortex.
DHEAS circulates at substantially higher concentrations than DHEA and has a longer circulating half-life, making it a useful clinical marker of adrenal androgen production.
Androstenedione is another androgen precursor produced by the adrenal glands as well as the gonads.
Peripheral tissues can convert androstenedione into testosterone or estrogens depending on the enzymes expressed within those tissues.
| Hormone | Major Feature |
|---|---|
| DHEA | Weak androgen and important steroid precursor |
| DHEAS | Sulfated adrenal androgen with high circulating concentration and long half-life |
| Androstenedione | Precursor capable of conversion to testosterone and estrogens |
Like all adrenal cortical steroid hormones, adrenal androgens are synthesized from cholesterol.
Cholesterol is transported into mitochondria, where steroidogenesis begins with its conversion to pregnenolone.
Cholesterol is the common precursor for mineralocorticoids, glucocorticoids, and adrenal androgens.
Adrenal cortical cells obtain cholesterol from circulating lipoproteins and intracellular stores and can also synthesize cholesterol.
A critical early step in steroidogenesis is the movement of cholesterol to the inner mitochondrial membrane.
The steroidogenic acute regulatory protein (StAR) plays an important role in facilitating this process.
Within mitochondria, cholesterol is converted to pregnenolone by the cholesterol side-chain cleavage enzyme.
Pregnenolone then serves as a precursor for several adrenal steroidogenic pathways.
In the zona reticularis, steroidogenesis is directed substantially toward formation of C19 androgen precursors.
A simplified pathway is:
Cholesterol → Pregnenolone → 17-Hydroxypregnenolone → DHEA → Androstenedione → Peripheral sex steroids
The enzyme CYP17A1 has both 17α-hydroxylase and 17,20-lyase activities and is essential for adrenal androgen synthesis.
Its 17,20-lyase activity facilitates formation of DHEA from 17-hydroxypregnenolone.
Enhanced 17,20-lyase activity within the zona reticularis favors production of androgen precursors rather than directing all available steroid intermediates toward glucocorticoid synthesis.
DHEA can undergo sulfation to form DHEAS.
This reaction is catalyzed primarily by the sulfotransferase enzyme SULT2A1, which is highly expressed in the zona reticularis.
The enzyme expression pattern of the zona reticularis favors production of DHEA and DHEAS.
This biochemical specialization distinguishes the zona reticularis from the neighboring zona fasciculata, which is primarily specialized for cortisol production.
| Step | Product or Process |
|---|---|
| Initial substrate | Cholesterol |
| First steroid intermediate | Pregnenolone |
| Important hydroxylated intermediate | 17-Hydroxypregnenolone |
| Major adrenal androgen | DHEA |
| Sulfated product | DHEAS |
| Additional androgen precursor | Androstenedione |
Adrenocorticotropic hormone (ACTH) is an important regulator of adrenal androgen production.
ACTH is secreted by corticotroph cells of the anterior pituitary and acts on cells of the adrenal cortex.
The hypothalamic-pituitary-adrenal axis provides the principal endocrine pathway regulating ACTH secretion.
Corticotropin-releasing hormone from the hypothalamus stimulates ACTH release from the anterior pituitary, which subsequently stimulates the adrenal cortex.
ACTH binds to melanocortin 2 receptors on adrenal cortical cells.
Receptor activation stimulates intracellular signaling pathways that promote cholesterol availability and steroid hormone synthesis.
ACTH increases steroidogenic activity by influencing several steps involved in cholesterol transport and steroid synthesis.
Because the zona reticularis is responsive to ACTH, changes in ACTH secretion can alter adrenal androgen production.
Both cortisol and adrenal androgen production are influenced by ACTH. However, their developmental patterns and detailed regulation are not identical.
Adrenal androgen production undergoes characteristic age-related changes that are particularly evident during adrenarche.
Adrenarche is the developmental increase in adrenal androgen production that occurs during childhood, typically before the full activation of gonadal puberty.
It is associated with maturation of the zona reticularis and increasing secretion of DHEA and DHEAS.
Adrenarche and gonadal puberty are related developmental processes but are not identical.
Adrenarche reflects increased adrenal androgen production, whereas gonadal puberty is driven primarily by activation of the hypothalamic-pituitary-gonadal axis.
Increasing adrenal androgen production contributes to several secondary changes during childhood and adolescence.
These can include:
Pubarche refers to the appearance of pubic hair associated with increasing androgen action.
Adrenal androgens are important contributors to pubarche, particularly during normal adrenarche.
Adrenal androgen production changes substantially with age.
Levels are relatively low during early childhood, rise during adrenarche, reach high concentrations during early adulthood, and generally decline progressively with advancing age.
DHEAS concentrations show a particularly prominent age-related pattern.
After increasing during adrenarche and reaching relatively high levels in young adulthood, circulating DHEAS generally decreases progressively later in life.
The direct androgenic potency of DHEA and DHEAS is relatively weak.
Much of their physiological importance results from their ability to act as precursors for locally produced testosterone, dihydrotestosterone, and estrogens.
Adrenal androgen precursors can be taken up by peripheral tissues and converted enzymatically into more active sex steroids.
The final hormonal effect therefore depends partly on the enzymes expressed within individual tissues.
Androstenedione can be converted into testosterone by enzymes present in peripheral tissues.
DHEA can also contribute indirectly to testosterone production after conversion through intermediate steroids.
Testosterone derived from adrenal androgen precursors can undergo further conversion to dihydrotestosterone (DHT) in tissues expressing 5α-reductase.
DHT is a potent androgen acting through the androgen receptor.
Androstenedione and testosterone derived from adrenal precursors can undergo aromatization to form estrogens.
Adrenal androgens therefore contribute not only to androgenic activity but also to peripheral estrogen production.
Some tissues convert circulating adrenal androgen precursors into active sex steroids locally and use those hormones within the same tissue.
This local production and action is often described as intracrine steroid metabolism.
Adrenal androgens represent an important component of androgen production in females.
They contribute to androgen-dependent features such as pubic and axillary hair and provide precursors for peripheral androgen and estrogen synthesis.
In adult males with normal testicular function, the testes produce much larger quantities of potent androgen, particularly testosterone.
Consequently, adrenal androgen secretion generally contributes a smaller proportion of total androgenic activity than it does in females.
| Feature | Adrenal Androgens | Major Gonadal Androgens |
|---|---|---|
| Major source | Zona reticularis | Primarily testes in males, with ovarian androgen production in females |
| Representative hormones | DHEA, DHEAS, androstenedione | Testosterone |
| Intrinsic androgenic potency | Generally weak | Greater |
| Major regulatory pathway | ACTH-related regulation | Gonadotropin regulation |
| Important role | Peripheral sex steroid precursors | Direct systemic androgen action |
Adrenal androgenic steroids circulate in different forms and with different degrees of protein binding.
DHEAS is highly water soluble relative to unconjugated steroid hormones because of its sulfate group and circulates at much higher concentrations than DHEA.
The relatively high concentration and long half-life of DHEAS allow it to function as a substantial circulating pool of adrenal androgen precursor.
Peripheral tissues capable of steroid metabolism can participate in conversion of adrenal precursors into biologically active hormones.
Because DHEAS is produced predominantly by the adrenal glands and has relatively stable circulating concentrations, measurement of DHEAS can help assess whether androgen excess is likely to have an adrenal component.
Excessive adrenal androgen production can produce signs of androgen excess, particularly in females and children.
The manifestations depend on the patient's age, sex, severity of hormone excess, and specific steroids produced.
Potential manifestations include:
Hirsutism refers to excessive terminal hair growth in androgen-sensitive areas in females.
Adrenal androgen excess is one possible contributor, although hirsutism has multiple potential endocrine and non-endocrine causes.
Virilization describes the development of more pronounced androgenic features resulting from substantial androgen exposure.
Rapid or marked virilization can indicate significant androgen excess and warrants evaluation of both adrenal and gonadal sources.
Premature adrenarche refers to an earlier-than-expected increase in adrenal androgen production.
It may present with premature pubic or axillary hair, body odor, or other androgen-dependent changes without complete activation of gonadal puberty.
Congenital adrenal hyperplasia (CAH) comprises inherited disorders of adrenal steroidogenesis caused by deficiencies of specific steroidogenic enzymes.
Some forms reduce cortisol synthesis and redirect steroid precursors toward androgen production, producing adrenal androgen excess.
21-hydroxylase deficiency is the most common cause of congenital adrenal hyperplasia.
Reduced cortisol synthesis decreases normal negative feedback on ACTH secretion. Increased ACTH stimulation and accumulation of steroid precursors can result in excessive adrenal androgen production.
When cortisol synthesis is impaired, reduced negative feedback can increase ACTH secretion.
Chronic ACTH stimulation promotes adrenal cortical hyperplasia and increases steroid production upstream of the enzymatic block.
In some forms of CAH, steroid intermediates that cannot proceed efficiently through the normal cortisol pathway are diverted toward androgen synthesis.
This biochemical rerouting explains the association between certain enzyme deficiencies and androgen excess.
Adrenal cortical tumors can occasionally produce excessive quantities of androgenic steroids.
Markedly elevated adrenal androgen concentrations, particularly when accompanied by rapid clinical progression, can prompt investigation for an adrenal source.
Adrenocortical carcinoma can produce cortisol, androgens, mineralocorticoids, estrogens, or combinations of steroid hormones.
Androgen secretion from an adrenal cortical neoplasm may produce rapidly developing signs of androgen excess.
Disorders associated with excessive ACTH stimulation can affect multiple steroidogenic pathways within the adrenal cortex.
Depending on the underlying cause, adrenal androgen concentrations may therefore change together with cortisol production.
When ACTH concentrations are chronically elevated, stimulation of both the zona fasciculata and zona reticularis can increase production of cortisol and adrenal androgen precursors.
When cortisol is produced autonomously by an adrenal lesion, suppression of pituitary ACTH may reduce stimulation of nonautonomous adrenal cortical tissue.
Adrenal androgen concentrations may consequently be lower in some ACTH-independent states.
Primary adrenal insufficiency damages the adrenal cortex and can reduce production of cortisol, aldosterone, and adrenal androgens to varying degrees.
Loss of adrenal androgen production can be more clinically apparent in females because adrenal steroids contribute more substantially to their total androgen pool.
In primary adrenal cortical failure, reduced zona reticularis function can decrease DHEA and DHEAS production.
This occurs together with deficiencies involving other adrenal cortical steroid pathways.
Reduced ACTH stimulation can decrease cortisol and adrenal androgen production.
Mineralocorticoid secretion is comparatively preserved because aldosterone regulation depends predominantly on the renin-angiotensin system and extracellular potassium concentration rather than ACTH.
Laboratory evaluation of suspected adrenal androgen abnormalities may include measurement of specific circulating steroids and steroid precursors.
The tests selected depend on the clinical presentation and suspected disorder.
DHEAS is commonly measured when evaluating androgen excess because it is produced predominantly by the adrenal cortex.
Its relatively long half-life and limited short-term fluctuation also make it useful for assessing adrenal androgen production.
DHEA can also be measured, although its circulating concentration varies more than DHEAS and it has a shorter half-life.
Androstenedione measurement can provide additional information about androgen synthesis but does not uniquely identify an adrenal source because both the adrenal glands and gonads can produce it.
17-Hydroxyprogesterone is an important steroid precursor measured particularly when evaluating suspected 21-hydroxylase deficiency.
Elevated concentrations can indicate impaired progression through the normal steroidogenic pathway.
ACTH stimulation testing can be used in the evaluation of selected disorders of adrenal steroidogenesis.
Changes in cortisol and steroid precursor concentrations following ACTH administration can help characterize adrenal enzymatic function.
Determining the source of androgen excess requires consideration of the pattern of hormone abnormalities rather than measurement of a single androgen alone.
DHEAS is particularly useful because its production is predominantly adrenal, whereas testosterone and androstenedione can arise from both adrenal and gonadal pathways.
| Hormone | Clinical Interpretation |
|---|---|
| DHEAS | Useful marker of adrenal androgen production |
| DHEA | Adrenal androgen precursor with greater short-term variation |
| Androstenedione | Can originate from adrenal glands or gonads |
| Testosterone | Potent androgen with important gonadal and peripheral sources |
| 17-Hydroxyprogesterone | Important in assessment of selected steroidogenic enzyme defects |
Adrenal androgen and cortisol synthesis share cholesterol and several early steroidogenic steps.
The final hormonal products depend on the enzymes and cofactors expressed within different zones of the adrenal cortex.
| Feature | Zona Fasciculata | Zona Reticularis |
|---|---|---|
| Location | Middle adrenal cortical layer | Inner adrenal cortical layer |
| Major product | Cortisol | DHEA and DHEAS |
| Major regulator | ACTH | ACTH-related regulation |
| Principal steroid role | Glucocorticoid activity | Androgen precursor production |
The zona glomerulosa is specialized for aldosterone production and lacks significant CYP17A1 activity.
It therefore does not normally contribute substantially to adrenal androgen synthesis.
The functional specialization of adrenal cortical zones reflects differences in steroidogenic enzyme expression.
Although all cortical zones derive steroid hormones from cholesterol, they produce different final products because they express different combinations and activities of enzymes.
Potent androgens derived from adrenal precursors can exert biological effects through the androgen receptor, an intracellular nuclear receptor expressed in numerous tissues.
DHEA and DHEAS themselves have much weaker direct androgenic effects than testosterone or DHT.
The enzyme aromatase converts androgenic steroids into estrogens.
Peripheral aromatization allows adrenal androgen precursors to contribute indirectly to estrogen production.
Tissues capable of metabolizing adrenal androgen precursors include adipose tissue, skin, hair follicles, bone, and reproductive tissues.
The steroid produced locally depends on the combination of steroidogenic enzymes present in the tissue.
Skin and hair follicles contain enzymes capable of metabolizing androgen precursors.
This local metabolism contributes to the effects of adrenal androgens on pubic and axillary hair, sebaceous glands, and other androgen-sensitive structures.
Increasing androgen activity during adrenarche and puberty stimulates sebaceous gland activity.
This relationship contributes to the association between increasing androgen levels and development of acne.
Adrenal androgen activity contributes to maturation and increased activity of apocrine glands during adrenarche.
This is associated with changes in body odor that commonly accompany this developmental stage.
Adrenal androgen precursors can be converted into active sex steroids within peripheral tissues, including bone.
Sex steroids influence skeletal growth, maturation, and maintenance, although gonadal hormones become the dominant sex steroid source during normal puberty.
The fetal adrenal gland has a distinctive organization that differs from the adult adrenal cortex.
A prominent fetal zone produces large quantities of DHEA sulfate, which participates in fetoplacental steroid metabolism.
The fetal zone forms a large proportion of the fetal adrenal cortex.
It produces androgen precursors, particularly DHEAS, that can be used by the placenta for estrogen synthesis.
During pregnancy, fetal adrenal DHEAS provides an important precursor for placental estrogen production.
The placenta modifies these fetal adrenal steroids through its own steroidogenic pathways.
After birth, the fetal adrenal zone undergoes substantial involution.
The adrenal cortex subsequently develops toward its characteristic postnatal zonation and later undergoes further maturation associated with adrenarche.
| Feature | DHEA/DHEAS | Testosterone |
|---|---|---|
| Major adrenal source | Zona reticularis | Only limited direct adrenal production |
| Androgenic potency | Weak | Strong |
| Role as precursor | Major role | Can itself be converted to DHT or estradiol |
| Circulating DHEAS form | Very abundant | Not applicable |
DHT is considerably more potent at the androgen receptor than the major adrenal androgen precursors.
Adrenal steroids can nevertheless contribute indirectly to DHT production after peripheral conversion through intermediate androgens.
| Feature | Key Point |
|---|---|
| Primary site of production | Zona reticularis of adrenal cortex |
| Major hormones | DHEA, DHEAS and androstenedione |
| Precursor | Cholesterol |
| Important enzyme | CYP17A1 |
| DHEA sulfation enzyme | SULT2A1 |
| Major regulatory hormone | ACTH |
| Developmental increase | Adrenarche |
| Intrinsic androgenic potency | Relatively weak |
| Major physiological role | Precursors for peripheral androgen and estrogen synthesis |
| Useful adrenal marker | DHEAS |
| Condition | Relationship to Adrenal Androgens |
|---|---|
| Premature adrenarche | Early increase in adrenal androgen production |
| Congenital adrenal hyperplasia | Some enzyme defects increase androgen synthesis |
| Adrenal androgen-producing tumor | Can produce marked androgen excess |
| Primary adrenal insufficiency | Reduced adrenal androgen production |
| ACTH deficiency | Can reduce adrenal androgen production |
| Hirsutism or virilization | May prompt evaluation for excessive adrenal androgen production |
Adrenal androgens represent an important functional product of the zona reticularis of the adrenal cortex. DHEA, DHEAS, and androstenedione are relatively weak androgens compared with testosterone and DHT, but they form an important circulating pool of precursors that can be converted into active androgens and estrogens within peripheral tissues.
Production increases during adrenarche and contributes to pubic and axillary hair development, sebaceous activity, and other androgen-dependent changes. Their relative physiological importance is greater in females because testicular testosterone production dominates androgen activity in adult males with normal gonadal function.
The steroidogenic pathway is also clinically important because abnormalities in adrenal enzyme activity, ACTH regulation, or adrenal cortical growth can substantially alter androgen production. Disorders such as congenital adrenal hyperplasia, adrenal cortical tumors, and adrenal insufficiency can therefore be associated with characteristic changes in adrenal androgen concentrations. Measurement of DHEAS is particularly useful when evaluating the adrenal contribution to androgen excess because circulating DHEAS is produced predominantly by the adrenal cortex.